Table 1.

DC yield (baseline to last ECP cycle day 2)

PatientsCD80+CD83+CD86+CD123+
− 3 + 2 + 2 − 2 
− 6 + 2 + 2 − 3 
− 2 + 2 + 3 − 4 
− 3 + 11 + 9 − 4 
− 5 + 3 + 2 − 2 
− 3 + 2 + 2 − 2 
− 4 + 6 + 5 − 3 
− 3 + 1.2 + 3 − 2 
− 3 + 2 + 6 
10 − 4 − 3 − 2 − 5 
PatientsCD80+CD83+CD86+CD123+
− 3 + 2 + 2 − 2 
− 6 + 2 + 2 − 3 
− 2 + 2 + 3 − 4 
− 3 + 11 + 9 − 4 
− 5 + 3 + 2 − 2 
− 3 + 2 + 2 − 2 
− 4 + 6 + 5 − 3 
− 3 + 1.2 + 3 − 2 
− 3 + 2 + 6 
10 − 4 − 3 − 2 − 5 

Cultured monocyte- and lymphocyte-derived DC subpopulations were stained with CD80, CD123 (DC1) and CD83, CD86 (DC2) and were analyzed by flow cytometry at baseline, before ECP treatment, and at 12 months after initiation of ECP at the completion of day 2 of the treatment cycle. Results are shown as -fold difference, with each column demonstrating increases (+) or decreases (−). P< .005.

or Create an Account

Close Modal
Close Modal